Artemis Medicare Services Stock Screener | Share Price & Fundamental Analysis
ARTEMISMED
Hospitals
Screen Artemis Medicare Services share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹272.40
▼
-3.75 (-1.36%)
Share Price BSE
₹272.85
▼
-3.35 (-1.21%)
Market Cap
₹4,412.21 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.75
EPS (TTM)
₹5.37
Dividend Yield
0.14%
Debt to Equity
0.53
52W High
₹339.80
52W Low
₹218.35
Operating Margin
15.00%
Profit Margin
9.13%
Revenue (TTM)
₹252.00
EBITDA
₹48.00
Net Income
₹23.00
Total Assets
₹1,357.00
Total Equity
₹844.00
Artemis Medicare Services Share Price History - Stock Screener Chart
Screen ARTEMISMED historical share price movements with interactive charts. Analyze price trends and patterns.
Artemis Medicare Services Company Profile - Fundamental Screener
Screen Artemis Medicare Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ARTEMISMED shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE025R01021
Artemis Medicare Services Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ARTEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 1,357 | 972 | 905 | 710 | 600 | 586 | 554 |
| Current Assets | 539 | 180 | 170 | 127 | 110 | 118 | 113 |
| Fixed Assets | 745 | 719 | 605 | 489 | 383 | 393 | 381 |
| Liabilities | |||||||
| Total Liabilities | 1,357 | 972 | 905 | 710 | 600 | 586 | 554 |
| Current Liabilities | 298 | 332 | 292 | 210 | 160 | 115 | 84 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 844 | 455 | 408 | 361 | 322 | 314 | 293 |
| Share Capital | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 824 | 435 | 390 | 346 | 307 | 300 | 280 |
Screen ARTEMISMED income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 252 | 262 | 282 | 227 | 228 | 249 | 241 | 198 | 211 | 227 | 221 | 151 | 170 | 189 | 189 |
| Expenses | 204 | 214 | 224 | 187 | 187 | 199 | 195 | 170 | 182 | 191 | 186 | 132 | 148 | 164 | 162 |
| EBITDA | 48 | 48 | 58 | 40 | 41 | 50 | 46 | 28 | 29 | 37 | 34 | 18 | 22 | 25 | 27 |
| Operating Profit % | 15.00% | 16.00% | 18.00% | 17.00% | 16.00% | 18.00% | 16.00% | 13.00% | 13.00% | 15.00% | 15.00% | 11.00% | 11.00% | 13.00% | 14.00% |
| Depreciation | 12 | 11 | 12 | 11 | 11 | 11 | 11 | 9 | 9 | 10 | 10 | 6 | 7 | 7 | 8 |
| Interest | 8 | 7 | 7 | 9 | 8 | 8 | 8 | 5 | 7 | 8 | 8 | 4 | 4 | 5 | 5 |
| Profit Before Tax | 29 | 30 | 39 | 20 | 22 | 31 | 27 | 14 | 13 | 19 | 16 | 8 | 11 | 13 | 13 |
| Tax | 6 | 9 | 9 | 6 | 5 | 8 | 6 | 3 | 3 | 5 | 5 | -5 | 2 | 4 | 3 |
| Net Profit | 23 | 21 | 30 | 14 | 17 | 22 | 21 | 11 | 10 | 14 | 12 | 13 | 8 | 9 | 10 |
| EPS | 1.47 | 1.35 | 1.90 | 1.04 | 1.14 | 1.42 | 1.32 | 0.79 | 0.72 | 1.00 | 0.85 | 1.00 | 0.64 | 0.68 | 0.78 |
Artemis Medicare Services Cash Flow Screener - Liquidity Fundamentals
Screen ARTEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 146 | 109 | 127 | 60 | 27 | 56 | 41 |
| Investing Activities | -385 | -88 | -158 | -107 | -37 | -26 | -50 |
| Financing Activities | 267 | -29 | 38 | 44 | 18 | -27 | 14 |
| Net Cash Flow | 27 | -8 | 7 | -4 | 8 | 2 | 5 |
Screen ARTEMISMED shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 67.17% | 66.53% | 66.53% | 58.43% | 68.03% | 67.51% | 67.17% | 67.17% |
| FII Holding | 0.31% | 0.24% | 0.37% | 12.48% | 0.10% | 0.16% | 0.22% | 0.64% |
| DII Holding | 5.04% | 4.76% | 4.27% | 3.35% | 2.61% | 3.45% | 3.60% | 4.50% |
| Govt Holding | 7.09% | 7.02% | 7.02% | 6.16% | 7.18% | 7.12% | 7.09% | 7.09% |
| Public Holding | 12.86% | 12.93% | 13.44% | 11.65% | 14.74% | 14.23% | 13.89% | 12.76% |
| Other Holding | 7.53% | 8.52% | 8.37% | 7.93% | 7.34% | 7.53% | 8.03% | 7.84% |
| Shareholder Count | 28,397 | 31,614 | 33,559 | 31,884 | 19,993 | 19,795 | 26,054 | 27,003 |
Artemis Medicare Services Dividend Screener - Share Yield Analysis
Screen ARTEMISMED dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.45 | 0.17% |
| 2024-March | ₹0.45 | 0.16% |
| 2023-March | ₹0.45 | 0.26% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Artemis Medicare Services Index Membership - Market Screener Classification
Screen ARTEMISMED by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Artemis Medicare Services Market Events Screener - Corporate Actions
Screen ARTEMISMED market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 0.02% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 6.20% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | -3.97% |
| 2025-07-11 | 2025-07-11 | Dividend | ₹ 0.45 /share | 5.08% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -8.22% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 2.93% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.84% |
| 2024-07-24 | 2024-07-24 | Annual General Meeting | NA | 23.92% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.45 /share | -4.82% |
| 2024-05-03 | 2024-05-03 | Extraordinary General Meeting | NA | -2.08% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 0.45 /share | 57.34% |
Artemis Medicare Services Competitors Screener - Peer Comparison
Screen ARTEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 102,252 | 58.57 | 21,994 | 14.76% | 1,505 | 46.86 |
| Max Healthcare Institute | 102,082 | 74.90 | 7,184 | 28.65% | 1,076 | 38.86 |
| Fortis Healthcare | 67,988 | 64.26 | 7,850 | 13.25% | 809 | 49.90 |
| Narayana Hrudayalaya | 39,532 | 45.71 | 5,575 | 12.29% | 790 | 57.19 |
| Global Health | 32,037 | 56.77 | 3,771 | 12.59% | 481 | 51.45 |
| Aster DM Healthcare | 31,434 | 87.54 | 4,287 | 15.12% | 337 | 40.34 |
| Krishna Institute of Medical Sciences | 24,653 | 68.29 | 3,067 | 21.98% | 415 | 33.50 |
| Dr. Agarwal's Health Care | 15,831 | 110.83 | 1,757 | 27.64% | 110 | 47.42 |
| Kovai Medical Center Hospital | 13,964 | 27.53 | 600 | 11.69% | 58 | 34.31 |
| Rainbow Childrens Medicare | 13,359 | 52.58 | 1,567 | 17.46% | 244 | 41.00 |
Artemis Medicare Services Company Announcements - News Screener
Screen ARTEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-08 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Conversion of Securities | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-11 | Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter/ Half Year Ended September 30 2025 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 11 2025 | View |
| 2025-11-05 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-04 | Board Meeting Intimation for Consideration Of Un-Audited Financial Results | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |